ABSTRACT
PURPOSE
This study aims to analyze the ability of quantitative dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) to distinguish between prostate cancer (PCa) and benign lesions in transition zone (TZ) and peripheral zone (PZ) using different methods for arterial input function (AIF) determination. Study endpoints are identification of a standard AIF method and optimal quantitative perfusion parameters for PCa detection.
METHODS
DCE image data of 50 consecutive patients with PCa who underwent multiparametric MRI were analyzed retrospectively with three different methods of AIF acquisition. First, a region of interest was manually defined in an artery (AIFm); second, an automated algorithm was used (AIFa); and third, a population-based AIF (AIFp) was applied. Values of quantitative parameters after Tofts (Ktrans, ve, and kep) in PCa, PZ, and TZ in the three different AIFs were analyzed.
RESULTS
Ktrans and kep were significantly higher in PCa than in benign tissue independent from the AIF method. Whereas in PZ, Ktrans and kep could differentiate PCa (P < .001), in TZ only kep using AIFp demonstrated a significant difference (P = .039). The correlations of the perfusion parameters that resulted from AIFm and AIFa were higher than those that resulted from AIFp, and the absolute values of Ktrans, kep, and ve were significantly lower when using AIFp. The values of quantitative perfusion parameters for PCa were similar regardless of whether PCa was located in PZ or TZ.
CONCLUSION
Ktrans and kep were able to differentiate PCa from benign PZ independent of the AIF method. AIFa seems to be the most feasible method of AIF determination in clinical routine. For TZ, none of the quantitative perfusion parameters provided satisfying results.
Main points
• Automated AIF can be used as a standard user-independent time saving method.
• Ktrans and kep can differentiate PCa from benign tissue in the peripheral prostate zone PZ.
• Quantitative DCE analysis was inferior for PCa detection in the TZ.
Most malignant tumors, such as prostate cancers (PCa), demonstrate altered perfusion. Higher vascular permeability, neo-angiogenesis with greater micro-vessel density, and arteriovenous shunts represent the main reasons.1 However, benign prostatic hyperplasia may also exhibit early perfusion and hinder accurate diagnosis of PCa especially in the transition zone (TZ) with magnetic resonance imaging (MRI) alone.2 Dynamic contrast-enhanced MRI (DCE-MRI) shows differences of perfusion of a defined region of interest (ROI) in the examined tissue based on the change of signal intensity (SI). The repetitive image acquisition of the same slices requires a certain temporal resolution, so that in order to provide clinical feasibility, the chosen T1-weighted sequence usually represents a compromise between spatial and temporal resolution.3 The SI changes over time can be converted into a concentration-time-curve (CTC), which provides information about the dynamics and distribution of contrast medium in the examined tissue.
The semi-quantitative analysis of DCE, integrated in the multiparametric protocol of PIRADS version 1 (together with T2- and diffusion-weighted imaging), has been exchanged for a qualitative and therefore, subjective analysis of DCE in version 2.4 Quantitative DCE as in Tofts model5 assumes two compartments in the examined tissue, representing extravascular extracellular space and blood plasma in an effort to provide absolute and therefore more objective values for perfusion.3 In this model, the constants for the exchange rate of contrast medium between the two compartments (Ktrans and kep) and the volume fraction of extracellular extravascular space within a voxel (ve) are calculated. Although other methods have shown promising results,6 the most common way to determine the perfusion parameters Ktrans, kep, and ve requires the determination of the arterial input function (AIF). Since the initial intravenous bolus of contrast medium becomes dispersed and delayed through the circulation, the AIF, which describes the time course of arterial contrast delivery to the tissue, is needed to interpret SI changes in the examined ROI. Thus, the AIF gives crucial information about tissue perfusion.
Objectivity and reproducibility of quantitative DCE analysis may ultimately endorse its routine use to optimize the detection of PCa in spite of the more complicated and time-consuming assessment. There are different methods for the acquisition of AIF. One common method suitable for clinical practice consists of drawing a ROI in a suitable artery such as the femoral artery manually. This manually acquired AIF requires further involvement of the radiologist. As an alternative, the AIF may be acquired by using automated algorithms, thus combining the advantage of a user independent and a patient specific AIF. Especially when a suitable artery is not available, the average of a population may serve as a solution. However, this population-based AIF is not specific to the examined patient. Since different methods for the determination of AIF, a standardized choice of method would be desirable for clinical and research purposes.7
The objective of this study was to compare values of quantitative perfusion parameters using Tofts two compartment model for PCa and physiologic tissue in TZ and peripheral zone (PZ) generated by three different methods of AIF determination.
Methods
Study design
The study included 50 patients with prostate MRI and subsequently detected PCa (March 2013 to July 2014). The same consecutive patient collective with PCa was evaluated previously regarding the influence of AIF acquisition method on quantitative perfusion parameters and zonal prostate anatomy. Index lesions with biopsy proven PCa using targeted in-bore MRI-guided biopsy were included in the evaluation. All patients received additional systematic transrectal ultrasound-guided biopsy. This study was conducted in a university hospital setting and has been approved by the institutional ethical review board (protocol number of ethics committee approval: 3612). All patients provided written informed consent.
Study endpoints
The primary endpoint is to demonstrate a significant difference of quantitative perfusion parameters (Ktrans, kep, and ve) between PCa and benign prostatic tissue. Secondary endpoints focused on differences of performance between automated (AIFa) and population-based (AIFp) AIF in comparison to manual AIF (AIFm) as a reference AIF.
Image acquisition, AIF determination, and quantitative perfusion parameter
The methods for image acquisition and for the determination of AIFm, AIFa, and AIFp have been published before.7, 8 For AIFm, a ROI was outlined in the common femoral artery. SI was converted into a CTC employing a linear approach by Mouridsen et al.9 and multi-flip-angle approach.10 For AIFa, the same slice as in AIFm was used. Cluster analysis with k-means function in MATLAB (MATLAB R R2011a, the Mathworks) was conducted. A ROI was created for AIFa if the number of voxels in a cluster was between 10 and 80. The temporal resolution of our data was integrated in Parker’s population-based AIF for AIFp.11
Quantitative perfusion parameters after extended Tofts model (Ktrans, ve, and kep) were determined for each dataset in PZPCa and TZ-PCa as well as in physiological PZ and TZ tissues in the dynamic T1-vibesequence. Ktrans and ve, best fitting the CTC of each ROI, were determined using the MATLAB-function fminsearch.ep was then calculated as the quotient of Ktrans and ve.5
Statistical analysis
Statistical analysis was performed with MATLAB (MATLAB R R2011a, the Mathworks). Data were examined for normal distribution with the KolmogorovSmirnov test. Non-normally distributed data for independent samples were analyzed with non-parametric Mann-Whitney U test. Normally distributed data were tested with the Student t test. P < .05 was considered significant. Furthermore, receiver operating characteristic (ROC) analyses were conducted for every parameter of each AIF method. Performance was assessed by calculating the respective areas under the ROC curve (AUCs) and the maximum Youden index (J) with corresponding cutoff value, sensitivity, and specificity for each method and perfusion parameter. Correlations were determined with Spearman correlation coefficient with a value for correlationcoefficient ρ between 0.7 and 0.9 considered as strong and a value for ρ greater than 0.9 as very strong.12 Descriptive statistics of the data are presented with n (%) and, for non-normalized variables, are shown as median (25-75 percentiles), and normally distributed data are shown as mean ± SD.
Results
Baseline characteristics with age, prostate-specific antigen (PSA), prostate volume, PSA density, and ISUP grade group separated by PCa localization (PZ or TZ) in the biopsied index lesions are shown in Table 1.
The absolute values of kep and Ktrans in PCa were significantly higher for AIFm, AIFa, and AIFp (P < .001), but not for ve (P = .898 in AIFm, P = .837 in AIFa, and P = .651 in AIFp). The Spearman correlation coefficient for the three different perfusion parameters Ktrans, ve, and kep between the different AIF methods AIFm, AIFa, and AIFp are given in Table 2 with a P <.001 for each correlation. Spearman correlation coefficient was highest for kep (ρ = 0.94 for AIFm, AIFa, ρ = 0.89 for AIFm-AIFp, and ρ = 0.86 for AIFa-AIFp). Both AIFm and AIFa display a similar CTC with a peak of approximately 1 mmol/L, whereas in AIFp, highest contrast medium concentration was 6 mmol/L.
Mean Ktrans, ve, and kep in PCa and in benign tissue with all three AIF methods is shown in Table 3 with their corresponding P values. The ROC curves reveal that kep has a greater AUC in comparison to Ktrans and ve with the highest value in AIFp (AUCmax = 0.859) (Figure 1a). Youden index was also generally greater for kep (J range: 0.52-0.61) in comparison to Ktrans (J range: 0.4-0.48) and ve (J range: 0.14-0.17) with the highest value in AIFp (Jmax = 0.61). Among the three methods, AIFp demonstrates greater AUCs and Youden indexes in comparison to AIFm and AIFa for the parameters Ktrans and kep.
Mean Ktrans, ve, and kep in PCa of PZ, PCa of TZ and in benign tissue in PZ or TZ with all three AIF methods are shown in Table 4. Differences between PCa in PZ and PCa in TZ were not statistically significant. When comparing PCa of PZ with benign tissue in PZ, Ktrans and kep demonstrate significantly different values in all three methods. The ROC curves reveal for PCa in PZ that Ktrans and kep have a greater AUC (AUC range: 0.849-0.890) and Youden indexes (J range: 0.55-0.68 for Ktrans; J range: 0.58-0.68 for kep) in comparison with ve (AUC range: 0.603-0.611) (J range: 0.26-0.32) (Figure 1b). Ktrans in AIFp has the highest AUC (AUCmax = 0.889) and Youden index (Jmax = 0.68), followed by kep in AIFp (AUC = 0.871, J = 0.67). For the differentiation of PCa in the TZ and benign TZ, P was only significant for kep in AIFp with a P < .001, an AUC of 0.75, and a J of 0.50 (Figure 1c). Examples of colored Ktrans, kep, and ve maps of PCAs in TZ and PZ are shown in Figures 2 and 3.
Discussion
This study verified the ability of quantitative perfusion parameters Ktrans and kep to distinguish PCa and benign prostate tissue in PZ, independent of the AIF method, while the performance in TZ was obviously inferior. This underlines a separate evaluation of each anatomical prostate zone.
Differences of absolute values of quantitative parameters gave rise to the question, in which AIF is best suited for PCa detection in clinical practice. The individualized nature of AIFa and AIFm, respecting patient’s specific physiology, constitutes a major advantage over AIFp. The similarities and the good correlation of results in AIFa and AIFm suggest that the cluster-based automated AIF generates acceptable results with the advantage of a user independent method.
Other authors have identified Ktrans and kep as best suited for differentiation of PZ and PCa.13, 14 Mehrabian et al.15 also demonstrated that Ktrans is capable to separate PCa and physiologic tissue in PZ, whereas ve failed in PCa detection in the study by Ocak et al.14 Bonekamp et al.16 have shown that DCE contributes to a higher sensitivity and specificity of PCa detection in PZ. Our data demonstrate good results for Ktrans and kep in all methods, while for TZ only kep resulting from AIFp-processing was significant. There is a great variety for absolute values of Ktrans between 0.16 (min−1)13 and 0.61 ± 0.83 (min−1)17 in AIFp in physiologic PZ and 0.75 (min−1).13 and 186 ± 1.19 (min−1)17 for PCa in current literature. Our Ktrans values measured by AIFa and AIFm are within that range.13, 17 Our values for kep in all methods are within the range of results by SanzRaquena et al.13 in physiologic tissue, but for PCa and using AIFp, our results are lower. Individual patient’s physiology affects the results in population-based AIFp, as a major explanation for the different values and the relatively low correlation with AIFm and AIFa for perfusion parameters Ktrans and ve.11We noticed a very high peak in the CTC of AIFp in comparison with AIFm and AIFa. It has been demonstrated by Meng et al.17 that higher peaks result in smaller values for Ktrans. Taking into account the relatively small sample size for TZ tumors and the deviating results for AIFp (especially kep) in comparison with the reported values of other authors, the results may be caused by a sampling error. However, quantitative perfusion values resulting from AIFm and AIFa were in a realistic range, while the differentiation between PCa and PZ was equal to those measured by AIFp. As AIFa is user independent and resulted in nearly the same perfusion values as the AIFm (as a standard method), this method seems to be most recommendable. The similar AUC values of Ktrans and kep in PZ demonstrate that quantitative DCE analysis distinguishes PCa and benign tissue in PZ independently from the chosen AIF method. Brunelle et al.18 found that the diagnostic performance of quantitative DCE parameters remains unchanged using different AIFs and MR imagers.
Absolute values of Ktrans and kep of PCa in TZ and physiologic TZ tissue generally differed. Although this finding was statistically not significant, it might promote the consideration of DCE not only in PZ but also in TZ. Thus, positive enhancement might support selection of index lesions or in case of circumscribed enhancement in correlating encapsulated hyperplasia nodules can rule out PCa. A major reason for the difficulty of PCa detection by DCE in TZ is probably the higher vascularization of TZ hyperplasia in comparison to normal PZ tissue.2 Also, current PI-RADS version (v2.1) supports qualitative DCE evaluation, since scientific evidence shows no clear benefit of quantitative DCE in PCa detection.19 While some authors are completely against the standardized application of contrast medium due to similar performance in PCa detection of bi-parametric MRI (bpMRI) without DCE to prevent side effects, save costs and time,20 a meta-analysis by Chen et al.21 further supports DCE.20, 21 DCE seems be especially useful in PI-RADS 3 and 4 category lesions patients.22 Therefore, PI-RADS v2.1 suggests that bpMRI is reserved for select clinical indications and multiparametric MRI with qualitative DCE analysis remains the standard approach.19 However, quantitative analysis of DCE promises comparability and reproducibility of results and may improve sensitivity or specificity in PCa detection not only in PZ but also in TZ. Ullrich and Schimmöller23 pointed out that lower inter-observer agreement caused i.a. =inter alia caused among others by the subjective nature of scoring criteria like used for qualitative DCE analysis. Future iterations of PI-RADS might include more quantitative analysis, if PCa detection can be improved compared to current purely qualitative assessment of DCE in version 2.1.
It has been shown previously that perfusion parameters differ significantly between benign PZ and TZ.7 This does not seem to apply to PCa, since our study demonstrates similar characteristics of perfusion with no differences between PCa in PZ or in TZ.
Beyond the retrospective nature, this study has some limitations. Since there are numerous other methods for the acquisition of AIF, the chosen three methods in this study are exemplary, but not complete. The main question of whether quantitative evaluation after Tofts actually performs better than qualitative DCE evaluation, for example, as employed in version 2.1 of PIRADS analysis in PCa detection has not been investigated in this study since identification of index lesion was based on qualitative DCE analysis representing a potential bias. In addition, the advantage of additional DCE over a bi-parametric approach (with T2-weighted imaging and DWI) has not been explored. Validation of imaging findings is limited to MRI-guided biopsy and does not include surgical specimen. Also, added false positive lesions using quantitative DCE methods have not been analyzed. Furthermore, the sample size of TZ lesion subgroup was relatively small.
In conclusion, all AIF methods demonstrate satisfying results for the differentiation of PCa and PZ tissue. For absolute values and comparison between centers, an automated AIF that respects patient’s individual physiology represents an attractive solution that does not require manual drawing of AIF by the radiologist. Quantitative DCE analysis seems inferior to identify PCa in TZ, but absolute results differed from physiologic tissue. This invites to consider DCE also for TZ lesions. The fact that all AIF methods allowed a differentiation of PCa and benign lesions and the good correlation for kep and Ktrans may support quantitative analysis in clinical practice. The objective approach could facilitate the comparison between different centers in the future. Moreover, quantitative analysis with Ktrans and kep could play an important role for therapy monitoring.


